Covered recipient · General Payments record
MICHAEL W CANNON
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$13,613.23
- Reported across 479 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $176.13 | 9 |
| Education | $14.17 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $31.13 | 1 |
| EISAI INC. | $20.54 | 1 |
| SOBI, INC | $20.09 | 1 |
| GlaxoSmithKline, LLC. | $19.95 | 1 |
| Daiichi Sankyo Inc. | $18.69 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $17.49 | 1 |
| Gilead Sciences, Inc. | $17.30 | 1 |
| TAIHO ONCOLOGY, INC. | $15.88 | 1 |
| Stemline Therapeutics Inc. | $15.06 | 1 |
| PFIZER INC. | $14.17 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Daiichi Sankyo Inc. | $18.69 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089405916 | CMS |
| Eisai Inc. | $20.54 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110765503 | CMS |
| Gilead Sciences, Inc. | $17.30 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133801436 | CMS |
| GlaxoSmithKline, LLC. | $19.95 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116687149 | CMS |
| Novartis Pharmaceuticals Corporation | $17.49 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086739197 | CMS |
| PFIZER INC. | $14.17 | 08/16/2024 | Education | Undisputed | 01/23/2026 | 1132059714 | CMS |
| SOBI, INC | $20.09 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141409402 | CMS |
| Stemline Therapeutics Inc. | $15.06 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142962141 | CMS |
| TAIHO ONCOLOGY, INC. | $15.88 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137942995 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $31.13 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144954573 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.